116 related articles for article (PubMed ID: 37024011)
1. Contextual fear expression engages a complex set of interactions between ventromedial prefrontal cortex cholinergic, glutamatergic, nitrergic and cannabinergic signaling.
Uliana DL; Diniz CRAF; da Silva LA; Borges-Assis AB; Lisboa SF; Resstel LBM
Neuropharmacology; 2023 Jul; 232():109538. PubMed ID: 37024011
[TBL] [Abstract][Full Text] [Related]
2. The interaction between hippocampal cholinergic and nitrergic neurotransmission coordinates NMDA-dependent behavior and autonomic changes induced by contextual fear retrieval.
da Silva LA; Diniz CRAF; Uliana DL; da Silva-Júnior AF; Bertacchini GL; Resstel LBM
Psychopharmacology (Berl); 2022 Oct; 239(10):3297-3311. PubMed ID: 35978221
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of the contextual conditioned emotional response by CB1 and TRPV1 receptors in the ventromedial prefrontal cortex: Possible involvement of NMDA/nitric oxide-related mechanisms.
Uliana DL; Antero LS; Borges-Assis AB; Rosa J; Vila-Verde C; Lisboa SF; Resstel LB
J Psychopharmacol; 2020 Sep; 34(9):1043-1055. PubMed ID: 32638638
[TBL] [Abstract][Full Text] [Related]
4. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
5. Medial prefrontal cortex TRPV1 and CB1 receptors modulate cardiac baroreflex activity by regulating the NMDA receptor/nitric oxide pathway.
Lagatta DC; Kuntze LB; Ferreira-Junior NC; Resstel LBM
Pflugers Arch; 2018 Oct; 470(10):1521-1542. PubMed ID: 29845313
[TBL] [Abstract][Full Text] [Related]
6. Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats.
Terzian AL; dos Reis DG; Guimarães FS; Corrêa FM; Resstel LB
Psychopharmacology (Berl); 2014 Jan; 231(1):149-57. PubMed ID: 23922023
[TBL] [Abstract][Full Text] [Related]
7. Dorsal hippocampal muscarinic cholinergic receptors orchestrate behavioral and autonomic changes induced by contextual fear retrieval.
Diniz CRAF; da Silva LA; Bertacchini GL; da Silva-Júnior AF; Resstel LBM
Pharmacol Biochem Behav; 2022 Jul; 218():173425. PubMed ID: 35798059
[TBL] [Abstract][Full Text] [Related]
8. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex.
Resstel LB; Corrêa FM; Guimarães FS
Cereb Cortex; 2008 Sep; 18(9):2027-35. PubMed ID: 18158326
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
10. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
11. Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions.
Spiacci GB; Antero LS; Reis DG; Lisboa SF; Resstel LB
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1579-89. PubMed ID: 27591981
[TBL] [Abstract][Full Text] [Related]
12. M3 muscarinic receptor in the ventral medial prefrontal cortex modulating the expression of contextual fear conditioning in rats.
Fedoce AG; Ferreira-Junior NC; Reis DG; Corrêa FM; Resstel LB
Psychopharmacology (Berl); 2016 Jan; 233(2):267-80. PubMed ID: 26518024
[TBL] [Abstract][Full Text] [Related]
13. The expression of contextual fear conditioning involves activation of a NMDA receptor-nitric oxide-cGMP pathway in the dorsal hippocampus of rats.
Fabri DR; Hott SC; Reis DG; Biojone C; Corrêa FM; Resstel LB
Eur Neuropsychopharmacol; 2014 Oct; 24(10):1676-86. PubMed ID: 25174523
[TBL] [Abstract][Full Text] [Related]
14. The dorsolateral periaqueductal grey N-methyl-D-aspartate/nitric oxide/cyclic guanosine monophosphate pathway modulates the expression of contextual fear conditioning in rats.
Aguiar DC; Hott SC; Deolindo MV; Guimarães FS; Resstel LB
J Psychopharmacol; 2014 May; 28(5):479-85. PubMed ID: 24008812
[TBL] [Abstract][Full Text] [Related]
15. Medial prefrontal cortex N-methyl-D-aspartate receptor/nitric oxide/cyclic guanosine monophosphate pathway modulates both tachycardic and bradycardic baroreflex responses.
Ferreira-Junior NC; Fedoce AG; Alves FH; Resstel LB
J Neurosci Res; 2013 Oct; 91(10):1338-48. PubMed ID: 23913674
[TBL] [Abstract][Full Text] [Related]
16. Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning.
Resstel LB; Joca SR; Guimarães FG; Corrêa FM
Neuroscience; 2006 Dec; 143(2):377-85. PubMed ID: 16973302
[TBL] [Abstract][Full Text] [Related]
17. Functional lateralization in the medial prefrontal cortex control of contextual conditioned emotional responses in rats.
Gomes-de-Souza L; Busnardo C; Santos A; Paz HS; Resstel LB; Planeta CS; Nunes-de-Souza RL; Crestani CC
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111015. PubMed ID: 38653363
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CB
Sartim AG; Moreira FA; Joca SRL
Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
[TBL] [Abstract][Full Text] [Related]
19. CB
Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
[TBL] [Abstract][Full Text] [Related]
20. Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats.
Hott SC; Gomes FV; Uliana DL; Vale GT; Tirapelli CR; Resstel LB
Neuropharmacology; 2017 Jan; 112(Pt A):135-143. PubMed ID: 27256499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
